Skip to main content

Medipan GmbH

Company Profile

Medipan GmbH, founded in 1992  is an independent family company active in medical diagnostics, especially via immunological digital techniques for the fast & accurate diagnosis of autoimmune.

Located in Ludwig-Erhard-Ring 3, 15827 Blankenfelde-Mahlow OT Dahlewitz, south of Berlin, the company started with the marketing of radioimmunoassay products for the characterization of thyroid function, disease and tumour markers, with its partners from nuclear medicine laboratories, firstly within Germany and then soon from other countries. Later, the product portfolio expanded to include non-radioactive tests, and tests to detect autoantibodies found in patients suffering from autoimmune type 1 diabetes.

Medipan is a continuously growing company in the domestic and international diagnostic markets. In 2009, she became the first company in the world to introduce a commercially available system for the fully automated, objective evaluation of cell-based immunofluorescence tests: The AKLIDES® system marked a new milestone in the development of the immunofluorescence method – one of the oldest and most widespread laboratory procedures for the diagnosis of autoimmune diseases. The now-possible standardization and mathematically proven prediction of antibody concentration are the reasons that the system has received several awards.

Together with the sister company, GA Generic Assays GmbH, today Medipan GmbH, being active in over 70 countries, is an innovative and world-renowned partner for medical laboratories, physicians, medical institutes and research centres in the manufacture of manual detection test kits and automated systems in the following areas:

href=”https://www.medipan.de/products-category/elisa/”&amp;gt;&amp;amp;amp;lt;strong>ELISA&lt;/span> | <strong>Radioimmunoassay |>> Immunofluorescence assays | Lateral flow&lt;/span> | LINE/Dot assays</span></strong>

<strong>The target conditions include</strong>:

<p><p>Thyroid diseases | Type 1 diabetes | Rheumatoid arthritis | Polyendocrinopathies | Neuropathies | Vasculitis/Nephritis | Gastroenterology | Autoimmune hepatitis | Anti phospholipid syndrome | Complement system | Progressive systemic sclerosis | Atypical hemolytic-uremic syndrome | Pancreatitis | Systemic rheumatic inflammatory diseases | Celiac diseases | Crohn’s diseases | Myasthenia gravis

Public funding

Many of Medipan GmbH’s new developments are supported by public funding. The innovation performance of Medipan GmbH can thus be fully exploited and has contributed to the growth of the company especially in recent years.


European Regional Development Fund (EFRE) – Business Development 

Project: As part of the project, Medipan GmbH is developing a modular, AI-supported fluorescence microscopy system for automated autoimmune diagnostics. The system integrates high-performance optical components with intelligent control and analysis software for the standardized, digital evaluation of diagnostic samples. The aim is to create a technological platform that enables end-to-end automation and digitalization of laboratory-based diagnostic processes.

<strong data-start=”544″ data-end=”580″>Objectives and expected results:
The objective of the project is to develop a market-ready, innovative diagnostic system that significantly improves the objectivity, speed, and efficiency of clinical analyses. Expected outcomes include increased diagnostic accuracy, high reproducibility of results, and a reduction in manual evaluation steps. Furthermore, the project contributes to establishing new technological standards in AI-based image analysis and sustainably strengthens the innovative capacity and competitiveness of Medipan GmbH as well as the Brandenburg technology hub.

This image features the European Union flag on the left, which consists of a blue background with a circle of twelve yellow stars. To the right of the flag, there is text that reads: &amp;amp;amp;amp;quot;Co-funded by the European Union" in bold blue letters. The overall layout is simple and clear, emphasizing the message of European Union funding support. width=”333″ height=”70″ />


/>&lt;/p>

<p><p><p><p><p><p><p>/>

GRW Market Development – Participation in Fairs &amp;amp; Congresses

The earmarked grant for participation in trade fairs and congresses is awarded on the basis of the directive of the Ministry of Economic Affairs, Labour and Energy and through the financial participation of the State of Brandenburg.

Exhibition Location Date
WHX – World Health Expo Dubai February 10 – 13, 2026

17th Dresden Symposium on Autoantibodies

Dresden September 09 – 12,2025

Just Transition Fund (JTF) – Business Development

Project: Productive investments by SMEs (de minimis) Expansion of the capacities of an existing production facility


Cooperation

As an innovative technology company, Medipan GmbH attaches great importance to strong national and international networks as well as close cooperation with industry and science. This ensures the continuous development and improvement of our diagnostic detection methods.

Medipan GmbH
Ludwig-Erhard-Ring 3
15827 Blankenfelde-Mahlow OT Dahlewitz, Germany
Tel.: +49 33708 4417 – 0
Fax: +49 33708 4417 – 25
E-Mail: info@medipan.de
Website: www.medipan.de/en
General Manager/CEO: Prof. Dr. Dirk Roggenbuck
Registry Court: Amtsgericht Potsdam Registernummer: HRB 6195 P
VAT identification number: DE 811310408

Notice of Liability

Links&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt;/h4>

External, direct or indirect links on these webpages to webpages of other providers are given only as a link to the content of third parties; such content is not Medipan’s own. These links are recognizable from their context, or are explicitly identified as links. Medipan has no influence whatsoever on the content made available on suc

h third party websites, and does not make this content its own by providing the link. Medipan is not responsible for third party content or linked webpages in any way.</p>

Referrals

The author is not responsible for any contents linked or referred to from these pages – unless he has full knowledge of illegal contents and would be able to prevent the visitors of his site from viewing those pages. If any damage occurs by the use of information presented there, only the author of the respective pages might be liable, not the one who has linked to these pages. Furthermore the author is not liable for any postings or messages published by users of discussion boards, guest books or mailing lists provided on his page.

Content

The author reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected. Parts of the pages or the complete publication might be extended, changed or partly or completely deleted by the author without separate announcement.

<h4>Copyright</h4>

The author intended not to use any copyrighted material for the publication or, if not possible, to indicate the copyright of the respective object. The copyright for any material created by the author is reserved. Any duplication or use of objects such as diagrams, sounds or texts in other electronic or printed publications is not permitted without the author’s agreement.

Legal Notice

Medipan is not liable for the inability to access these webpages, the quality of access, the quality of reproduction of the webpages, for memory breakdown, viruses or other harmful code, disruptions of service, possible delays, errors, failures, or faulty transmissions.

The content made available by Medipan on these webpages is protected by copyright. The user may use and make copies (e.g. by printout) of parts of the content exclusively for private, non-commercial purposes.

Payment and Delivery Terms

All prices are in EURO (€) only. Medipan GmbH will deliver EX WORKS.

Payment terms are prepayment (payment in advance) unlike other written agreements.

Insurance, handling and shipping costs are not included. So transport costs have to be added to the invoice. Your own courier accounts may be accepted.

If any consignment should be damaged during transport, the buyer will be responsible to collect the claims from the forwarding agent, the transport company or the insurance company.

All fees, duties, taxes and other charges occurring with the sales and use of the purchased goods are to the expense of the buyer. The total price including all above mentioned additional costs are payable to:</p>

<p>

table {
width: 100%;
border-collapse: collapse;
}
th, td {
padding: 8px;
text-align: left;
}
Bank Deutsche Bank AG Sparkasse Oder-Spree
City, ZIP code Berlin, 14169 Frankfurt (Oder), 15230
Street Teltower Damm 2 Franz-Mehring Str. 22
Country Germany Germany
BIC (SWIFT) DEUTDEBBXXX WELA DED1LOS
IBAN DE12 1007 0000 0593 4500 00 DE23 1705 5050 1101 6292 70
VAT DE811310408 DE811310408

Please mention the invoice number you refer to during payment.

General Terms and Conditions

Contact us